Global Pet Diabetes Care Devices Market Insights and Forecast 2026–2030

April 8, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Anticoagulant Reversal Drugs Market Across 2026–2030?

The pet diabetes care devices market has experienced significant growth in recent years. It is anticipated to increase from $2.74 billion in 2025 to $2.98 billion in 2026, registering a compound annual growth rate (CAGR) of 9.0%. This historical expansion can be attributed to an escalating incidence of diabetes in pets, a heightened awareness of pet health, the development of veterinary healthcare infrastructure, the introduction of homecare monitoring devices, and a rise in pet ownership.

The market for pet diabetes care devices is anticipated to experience substantial expansion over the upcoming years. By 2030, its valuation is projected to reach $4.27 billion, demonstrating a compound annual growth rate (CAGR) of 9.4%. This projected increase during the forecast period stems from various factors, including enhancements in wearable glucose monitoring technology, the incorporation of AI into pet healthcare, increased usage of telemedicine for companion animals, the proliferation of smart pet care devices, and the expansion of subscription-based veterinary services. Key trends expected during this period encompass remote monitoring of pet health, wearable devices for diabetes tracking, customized insulin delivery methods, diabetes management integrated with mobile applications, and proactive health analytics tailored for pets.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9374&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Anticoagulant Reversal Drugs Market?

The growth of the pet diabetes care device market is anticipated to accelerate in the coming years due to the increasing number of pet owners. Pet ownership involves key responsibilities such as providing nourishment, hydration, shelter, physical activity, and healthcare for domesticated animals including dogs, cats, fish, birds, or other comparable small animals. These specialized devices are crucial for enhancing the welfare of diabetic pets by enabling precise monitoring, accurate treatment, and seamless communication between pet owners and veterinary professionals. Illustratively, in October 2023, data from the World Animal Foundation, a US-based website focused on animal rights, responsible pet ownership, and compassionate awareness, indicated that dog ownership was more widespread, accounting for 65.1 million dogs compared to 46.5 million cats. Additionally, eleven million homes feature saltwater fish tanks, in contrast to the 2.2 million horses owned by horse enthusiasts. Thus, the expansion in pet ownership is a significant catalyst for the pet diabetes care device market.

What Segmentation Levels Are Considered In The Anticoagulant Reversal Drugs Market?

The pet diabetes care devices market covered in this report is segmented –

1) By Device Type: Glucose Monitoring Devices, Insulin Delivery Devices

2) By Animal Type: Dogs, Cats, Horses

3) By Technology: Wearable Devices, Non-Wearable Devices

4) By Distribution Or Sales Channel: Veterinary Clinics & Hospitals, Retail & Online Pharmacies, Specialty Pet Stores

5) By End User: Veterinary Professionals, Pet Owners Or Home Care

Subsegments:

1) By Glucose Monitoring Devices: Blood Glucose Monitors (BGM), Continuous Glucose Monitors (CGM)

2) By Insulin Delivery Devices: Insulin Syringes, Insulin Pens, Insulin Pumps

What Trends Are Projected To Affect The Pet Diabetes Care Devices Market?

Leading businesses within the pet diabetes care device market are introducing advanced technologies to enhance their market standing. These cutting-edge technologies encompass sophisticated glucose monitoring systems, smart insulin delivery mechanisms, and digital health platforms designed to boost precision, simplify usage, and support extended diabetes management for pets. An example of this innovation is seen in February 2023, when Zoetis Inc., a US-based veterinary pharmaceutical firm, released the AlphaTrak 3 blood glucose monitoring system specifically for cats and dogs in the United States. The AlphaTrak 3 includes a new mobile application, enabling pet owners and veterinary professionals to collect, store, and transmit data. This system facilitates smooth data exchange and communication through its smartphone app, streamlining the real-time sharing of a pet’s glucose levels and critical information with veterinary clinics, thereby boosting confidence for both veterinarians and pet owners in managing diabetic pets. The AlphaTrak 3 blood glucose monitoring device provides precise readings in just five seconds, surpassing the speed of the earlier AlphaTrak 2 system. It requires only 0.3 microliters of blood and measures blood sugar levels ranging from 20 to 750 milligrams per deciliter. Furthermore, the updated AlphaTrak 3 mobile app collects more extensive data from pet owners compared to its predecessors, covering details like feeding, drinking, activity, and insulin administration schedules.

Which Leading Firms Are Contributing To The Growth Of The Anticoagulant Reversal Drugs Market?

Major companies operating in the pet diabetes care devices market are Allison Medical Inc., Zoetis Inc., Becton Dickinson and Company, Boehringer Ingelheim Vetmedica Inc., Henry Schein Animal Health, Apotex Inc., Merck Co. Inc., Trividia Health Inc., UltiMed Inc., ACON Laboratories Inc., i-SENS Inc., TaiDoc Technology Corporation, Abbott Laboratories, Novo Nordisk AS, Covetrus AG, Eli Lilly and Company, Bayer AG, Terumo Corporation, AccuBioTech Co. Ltd., ALR Technologies Inc.

Read the full pet diabetes care devices market report here:

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-devices-global-market-report

Which Regions Are Projected To Dominate The Anticoagulant Reversal Drugs Market In The Coming Years?

North America was the largest region in the pet diabetes care devices market in 2025. The regions covered in the pet diabetes care devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Anticoagulant Reversal Drugs Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9374&type=smp

Browse Through More Reports Similar to the Global Pet Diabetes Care Devices Market 2026, By The Business Research Company

Pet Diabetes Care Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-devices-global-market-report

Pet Healthcare Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/pet-healthcare-global-market-report

Veterinary Services Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795